Ubs Asset Management Americas Inc Bioventus Inc. Transaction History

Ubs Asset Management Americas Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.81 - $8.14 $100,474 - $451,859	55,511 New	55,511 $144,000
Q3 2021 Nov 15, 2021	SELL	$13.7 - $17.25 $154,741 - $194,838	-11,295 Reduced 2.82%	388,533 $5.5 Million
Q2 2021 Aug 16, 2021	BUY	$13.75 - $18.8 $5.5 Million - $7.52 Million	399,828 New	399,828 $7.04 Million

141

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $655M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.